Michele Marinò - Concepedia

Author

Michele Marinò

University of Pisa ORCID

Also Known As

C Marcocci, C. Erlichman, C. Marcocci, G. Lundell, M Marino, M Marinò, M Marinó, M P Di Marino, M. Marino, M. Marinò

245

Publications

Citations

H-Index

Concepts

All Affiliations

University of Pisa Azienda Ospedaliera Universitaria Pisana University of Insubria Harvard University Massachusetts General Hospital

About

Michele Marinò is an author at University of Pisa specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	40	3.7K
2	Health Sciences	2	2	135
3	Public Health	2	2	61
4	Natural Sciences	1	1	29
5	Allergy	1	1	31

Michele Marinò

Publications

Citations

H-Index

Page 1

	Year	Citations
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy Luigi Bartalena, George J. Kahaly, L. Baldeschi, European Journal of Endocrinology Translational MedicineParathyroid HormonePharmacologyThyroid DiseaseThyroid Disorders	2021	893
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO Luigi Bartalena, Lelio Baldeschi, Alison Dickinson, European Journal of Endocrinology Critical Care MedicineTourgent Surgical Decompression.cOphthalmologyOculoplasticsMild Go	2008	786
Teprotumumab for the Treatment of Active Thyroid Eye Disease Raymond S. Douglas, George J. Kahaly, Amy Patel, New England Journal of Medicine	2020	656
Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy Luigi Bartalena, Lelio Baldeschi, Alison Dickinson, Thyroid Thyroid DiseaseSurgeryConsensus StatementMedicineEuropean Group	2008	406
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial George J. Kahaly, Michaela Riedl, J. König, The Lancet Diabetes & Endocrinology Methylprednisolone Versus MethylprednisoloneEndocrine DiseaseMedicineClinical TrialsMulticentre Trial	2018	212
Acute and Severe Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy in Patients with Graves' Ophthalmopathy Michele Marinò, Eugenia Morabito, Maurizia Rossana Brunetto, Thyroid Ocular DiseaseHepatologyOphthalmologyAcute Liver FailureGlaucoma	2004	168
Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement Petros Perros, László Hegedüs, Luigi Bartalena, Orphanet Journal of Rare Diseases	2017	168
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment Raymond S. Douglas, George J. Kahaly, Shoaib Ugradar, Ophthalmology	2021	148
Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? Stefano Mariotti, Giuseppe Barbesino, Patrizio Caturegli, The Journal of Clinical Endocrinology & Metabolism Unobtainable GoalImmunologyPathologySerum TgImmunotherapy	1995	130
Effects of Total Thyroid Ablation Versus Near-Total Thyroidectomy Alone on Mild to Moderate Graves’ Orbitopathy Treated with Intravenous Glucocorticoids Francesca Menconi, Michele Marinò, Aldo Pinchera, The Journal of Clinical Endocrinology & Metabolism	2007	130

Page 1